31 maart 2005: Menopause. 2004 Jul-Aug;11(4):400-4.

Genisteïne gaat opvliegers significant tegen blijkt uit dubbelblinde gerandomiseerde studie bij 90 gezonde vrouwen van 47 tot 57 jaar in de overgang gedurende 1 jaar follow-up. De onderzoekers zien voor genisteïne een natuurlijke rol weggelegd i.p.v. extra aanvullende hormoontherapie voor vrouwen in de overgang.

Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study.

Crisafulli A, Marini H, Bitto A, Altavilla D, Squadrito G, Romeo A, Adamo EB, Marini R, D'Anna R, Corrado F, Bartolone S, Frisina N, Squadrito F.
Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Via C.Valeria, 98125 Gazzi, Messina, Italy.

OBJECTIVE: We evaluated and compared the effects of the phytoestrogen genistein, estrogen-progestogen therapy (EPT), and placebo on hot flushes and endometrial thickness in postmenopausal women. DESIGN: Ninety healthy, postmenopausal women, 47 to 57 years of age, were randomly assigned to receive for 1 year continuous EPT (n = 30; 1 mg 17beta-estradiol combined with 0.5 mg norethisterone acetate), the phytoestrogen genistein (n = 30; 54 mg/day), or placebo (n = 30). Endometrial safety was evaluated by intravaginal ultrasounds at baseline, 6 and 12 months.

RESULTS: By comparison with placebo, daily flushes reduced significantly by a mean of 22% (95% CI: -38 to -6.2; P < 0.01) after 3 months, by a mean of 29% (95% CI: -45 to -13; P < 0.001) after 6 months, and by a mean of 24% (95% CI: -43 to -5; P < 0.01) after 12 months of genistein treatment. Flush score decreased by a mean of 53% (95% CI: -79 to -26; P < 0.001) after 3 months, by a mean of 56% (95% CI: -83 to -28; P < 0.001) after 6 months, and by a mean of 54% (95% CI: -74 to -33; P < 0.001) after 12 months of EPT, as compared with placebo. No side effect was observed on the uterus of the participants.

CONCLUSIONS: The present study confirms that genistein might have positive effects on hot flushes without a negative impact on endometrial thickness and suggests a future role of this phytoestrogen as a strategically therapeutic alternative in the management of postmenopausal symptoms.

Randomized Controlled Trial
PMID: 15243277 [PubMed - indexed for MEDLINE]

Plaats een reactie ...

Reageer op "Genisteïne gaat opvliegers significant tegen blijkt uit dubbelblinde gerandomiseerde studie bij 90 gezonde vrouwen van 47 tot 57 jaar in de overgang gedurende 1 jaar follow-up."


Gerelateerde artikelen
 

Gerelateerde artikelen

Genisteïne en indole-3-carbinol >> Genisteine als aanvulling >>